ANTX: AN2 Therapeutics, Inc. Stock

by  •  • Comments Off on ANTX: AN2 Therapeutics, Inc. Stock

SIC 6324 – Hospital and Medical Service Plans

Valuation
Market Cap ($M) 73.24
Enterprise Value ($M) 57.59
Book Value ($M) 124.70
Book Value / Share 4.19
Price / Book 0.59
NCAV ($M) 96.46
NCAV / Share 3.24
Price / NCAV 0.76

Profitability (mra)
Return on Invested Capital (ROIC) -0.52
Return on Assets (ROA) -0.71
Return on Equity (ROE) -0.78

Liquidity (mrq)
Quick Ratio 7.87
Current Ratio 7.87

Balance Sheet (mrq) ($M)
Current Assets 110.51
Assets 138.74
Liabilities 14.04
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -69.64
Net Income -64.73
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -53.29
Cash from Investing -43.28
Cash from Financing 84.99

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Citadel Advisors Llc 5.20
02-14 13G/A Ra Capital Management, L.p. 18.70 47.11
02-13 13G Easom Eric 5.20
02-12 13G/A Janus Henderson Group Plc 4.30 27.99
02-09 13G/A TCG Crossover GP I, LLC 9.00 107.72
02-09 13G/A Adjuvant Global Health Technology Fund, L.P. 8.30 -4.77

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-18 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 37,217 130,317 28.56
2024-04-17 19,393 72,568 26.72
2024-04-16 17,244 66,097 26.09
2024-04-15 75,444 192,659 39.16

(click for more detail)

Similar Companies
ALHC – Alignment Healthcare, Inc. CLOV – Clover Health Investments, Corp.
PFG – Principal Financial Group, Inc.


Financial data and stock pages provided by
Fintel.io